Physician profile
Emalee Gullick
NPI 1831705565
$387.85
in general payments reported to CMS, 2019-2025
9 companies · $53.89 in 2025
The $53.89 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.72 · 2022: $203 · 2023: $87.44 · 2024: $16.20 · 2025: $53.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $106.15 | 2022 | |
| Zimmer Biomet Holdings, INC. | $87.44 | 2023 | Comprehensive Shoulder System, Gel-One Cross-Linked Hyaluronate, Rosa |
| Bioventus LLC | $36.89 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $35.92 | 2024-2025 | Zilretta, Exparel, Iovera |
| Convatec INC. | $34.17 | 2025 | |
| Abbvie INC. | $33.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.61 | 2022 | |
| Genentech USA, INC. | $16.67 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emalee Gullick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.